INVIVO ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES EXPANDED IN RECOMBINANT INTERLEUKIN-2

被引：1
|
作者：
SPIESS, PJ [1 ]
YANG, JC [1 ]
ROSENBERG, SA [1 ]
机构：
[1] US PHS, NCI,DIV CANC TREATMENT,SURG BRANCH,BLDG 10, ROOM 2B44, BETHESDA, MD 20892 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1987年 / 79卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1067 / 1075
页数：9
相关论文
共 50 条
  • [21] Antitumour activity of expanded human tumor-infiltrating γδ T lymphocytes
    Chen, J
    Niu, HT
    He, W
    Ba, DN
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2001, 125 (03) : 256 - 263
  • [22] Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2
    Tamada, K
    Harada, M
    Okamoto, T
    Takenoyama, M
    Ito, O
    Matsuzaki, G
    Nomoto, K
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (06) : 339 - 347
  • [23] ANTITUMOR-ACTIVITY AND SURFACE PHENOTYPES OF HUMAN GLIOMA-INFILTRATING LYMPHOCYTES AFTER INVITRO EXPANSION IN THE PRESENCE OF INTERLEUKIN-2
    SAWAMURA, Y
    HOSOKAWA, M
    KUPPNER, MC
    KOBAYASHI, H
    AIDA, T
    ABE, H
    DETRIBOLET, N
    CANCER RESEARCH, 1989, 49 (07) : 1843 - 1849
  • [24] TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 - RESPONSE
    ROSENBERG, SA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (04) : 319 - 319
  • [25] Tumor-infiltrating lymphocytes and interleukin-2: Dose and schedules of administration in the treatment of metastatic cancer
    Dillman, R
    Schiltz, P
    DePriest, C
    Barth, N
    Beutel, L
    de Leon, C
    O'Connor, A
    Nayak, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (06) : 730 - 737
  • [26] Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes
    Lee, Minjung
    Li, Jianfang
    Li, Jia
    Fang, Shaohai
    Zhang, Joanna
    Vo, Anh Tran Tram
    Han, Wei
    Zeng, Hongxiang
    Isgandarova, Sevinj
    Martinez-Moczygemba, Margarita
    Zhou, Yubin
    Sun, Deqiang
    Huang, Yun
    CANCER RESEARCH, 2021, 81 (08) : 1965 - 1976
  • [27] EFFECTS OF MURINE TUMOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION ON ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES
    WEBER, JS
    ROSENBERG, SA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (09) : 755 - 761
  • [28] INTERLEUKIN-2 EXPANDED TUMOR-INFILTRATING LYMPHOCYTES AND THEIR RESPONSE TO PREOPERATIVE ALPHA-INTERFERON IN PATIENTS WITH RENAL-CELL CARCINOMA
    FUJIOKA, T
    YOSHIDA, N
    HASEGAWA, M
    ISHIKURA, K
    SUZUKI, Y
    KUBO, T
    JOURNAL OF UROLOGY, 1994, 152 (03): : 852 - 856
  • [29] In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes - Results of a double gene marking trial
    Economou, JS
    Belldegrun, AS
    Glaspy, J
    Toloza, EM
    Figlin, R
    Hobbs, J
    Meldon, N
    Kaboo, R
    Tso, CL
    Miller, A
    Lau, R
    McBride, W
    Moen, RC
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02): : 515 - 521
  • [30] SYNERGISTIC ANTITUMOR-ACTIVITY OF INTERLEUKIN-2 AND CIMETIDINE AGAINST SYNGENEIC MURINE TUMOR
    NAKAJIMA, I
    CHU, TM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (01) : 9 - 14
12345